Hospira promotes 2, loses chief science officer
Hospira (NYSE:HSP) CSO and senior VP of R&D and medical and regulatory affairs resigned. Sumant Ramachandra’s left the Lake Forest, Ill.-based company on March 8.
Brian Smith, the former senior VP and general counsel, was appointed chief legal officer of Hospira. He will also keep his title of senior VP.
In another company shuffle, Royce Bedward was promoted to corporate VP, general counsel, and secretary. He formerly held the title of deputy general counsel and secretary.
Hill-Rom takes on another board member
William Kucheman will join the board at Hill-Rom Holdings (NYSE:HRC), the company announced. Kucheman was recently the interim CEO at Boston Scientific (NYSE:BSX), prior to which he worked as executive VP of the cardiology group and in global marketing positions.
Board chairman Rolf Classon said of Kucheman, "the combination of his strategic knowledge, operational experience and his background in sales and marketing adds valuable and complementary skills," according to a statement.
Finance VP leaving HeartWare
Lauren Farrell bid adieu to HeartWare International (NSDQ:HTWR) on March 1. The former VP of finance and principal accounting officer is entitled to her full severance package and the company said that she may do consulting work in the future. She will also no longer serve as Section 16 Reporting Officer.
Cibiem gets a new face in the corner office
On March 12, Ken Martin was named the new CEO and president of Cibiem, taking the place of the company’s co-founder and long acting CEO Howard Levin. Levin, who will continue as a board member, said in prepared remarks that Martin has "an impressive track record in leading successful medical device companies through commercialization and valuable strategic acquisitions."
Martin was previously CEO of Sadra Medical and VP of engineering at Hansen Medical. Martin has 20 years of experience in catheter and feedback device companies, and the board at Cibiem has said that they hope to move forward quickly with the company’s catheter-based approach for disease management.
Athrosurface officially names CEO
Steven Ek was named president and CEO of Athrosurface, effective November 2012. Ek has been a director since the company’s inception and was one of the original founders.
"Since launching the company in 2002, Steve has proven to be a highly effective leader and he has won the director of employees, customers and the Board," said Steve Tallarida, board chairman, in a statement. Ek previously worked as VP of engineering at STD Med and director of R&D at Smith & Nephew Endoscopy.